Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for MDXG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 281.00M
March 31, 2026 308.68M
December 31, 2025 342.65M
September 30, 2025 318.99M
June 30, 2025 291.11M
March 31, 2025 270.42M
December 31, 2024 263.92M
September 30, 2024 243.89M
June 30, 2024 230.18M
March 31, 2024 221.68M
December 31, 2023 239.05M
September 30, 2023 189.02M
June 30, 2023 176.38M
March 31, 2023 168.16M
December 31, 2022 171.43M
September 30, 2022 172.80M
June 30, 2022 168.67M
March 31, 2022 174.44M
December 31, 2021 187.93M
September 30, 2021 180.52M
June 30, 2021 187.15M
March 31, 2021 190.81M
December 31, 2020 202.03M
September 30, 2020 213.32M
June 30, 2020 150.91M
Date Value
March 31, 2020 158.91M
December 31, 2019 167.17M
September 30, 2019 179.27M
June 30, 2019 170.31M
March 31, 2019 107.44M
December 31, 2018 122.84M
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017 121.26M
September 30, 2017 178.71M
June 30, 2017 199.86M
March 31, 2017 188.49M
December 31, 2016 193.26M
September 30, 2016 181.66M
June 30, 2016 177.06M
March 31, 2016 177.22M
December 31, 2015 135.91M
September 30, 2015 125.93M
June 30, 2015 113.84M
March 31, 2015 106.10M
December 31, 2014 109.26M
September 30, 2014 97.32M
June 30, 2014 86.02M
March 31, 2014 87.35M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Anika Therapeutics, Inc. 183.47M
Perspective Therapeutics, Inc. 392.02M
ABVC BioPharma, Inc. 19.40M
Enovis Corp. 3.766B
Edwards Lifesciences Corp. 13.87B

Total Assets (Quarterly) Related Metrics